Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
JC Hiserodt, MR Graf, GA Granger - US Patent 6,277,368, 2001 - Google Patents
US6277368B1 - Cancer immunotherapy using autologous tumor cells combined with cells
expressing a membrane cytokine - Google Patents US6277368B1 - Cancer immunotherapy …
expressing a membrane cytokine - Google Patents US6277368B1 - Cancer immunotherapy …
Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancer
FCA Gaeta - US Patent 6,440,735, 2002 - Google Patents
The invention provides a method of activating a T lymphocyte by contacting the T
lymphocyte with a dendritic cell (DC) that presents a telomerase reverse transcriptase (TRT) …
lymphocyte with a dendritic cell (DC) that presents a telomerase reverse transcriptase (TRT) …
Cytokine-free culture of dendritic cells
M Vachula, DE Van Epps, MT Alzona… - US Patent …, 2002 - Google Patents
A method for producing human dendritic cells for therapeutic purposes which allows culture-
deriving dendritic cells using no cytokines, or reduced cytokines. The method involves …
deriving dendritic cells using no cytokines, or reduced cytokines. The method involves …
Vaccine immunotherapy
JW Hadden, K Signorelli, J Egan, P Naylor - US Patent 9,539,320, 2017 - Google Patents
2013-03-01 Assigned to IRX THERAPEUTICS, INC. reassignment IRX THERAPEUTICS,
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
Cell expansion
BJ Nankervis, ME Jones - US Patent 11,624,046, 2023 - Google Patents
Embodiments described herein generally provide for expanding cells in a cell expansion
system. The cells may be grown in a bioreactor, and the cells may be activated by an …
system. The cells may be grown in a bioreactor, and the cells may be activated by an …
Method of treating cancer
R Crystal, T Kikuchi - US Patent App. 10/421,351, 2003 - Google Patents
The present invention provides a method of treating cancer in a mammal comprising
administering to the mammal a dendritic cell-mediator, such as CD40L or MDC, and …
administering to the mammal a dendritic cell-mediator, such as CD40L or MDC, and …
Vaccine immunotherapy
JW Hadden, KL Signorelli, JE Egan… - US Patent …, 2017 - Google Patents
2013-05-24 Assigned to IRX THERAPEUTICS, INC. reassignment IRX THERAPEUTICS,
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
Vaccine immunotherapy
J Hadden - US Patent App. 11/492,418, 2007 - Google Patents
US20070025958A1 - Vaccine immunotherapy - Google Patents US20070025958A1 - Vaccine
immunotherapy - Google Patents Vaccine immunotherapy Download PDF Info Publication …
immunotherapy - Google Patents Vaccine immunotherapy Download PDF Info Publication …
Process for producing cytotoxic lymphocyte
H Sagawa, M Ideno, I Kato - US Patent 8,728,811, 2014 - Google Patents
The present invention relates to a method for preparing a cytotoxic lymphocyte characterized
in that the method comprises the step of carrying out at least one of induction, maintenance …
in that the method comprises the step of carrying out at least one of induction, maintenance …
Vaccine immunotherapy
JW Hadden, K Signorelli, J Egan - US Patent 9,492,517, 2016 - Google Patents
The present invention provides compositions and methods of immunotherapy to treat cancer
or other antigen-producing diseases or lesions. According to one embodiment of the …
or other antigen-producing diseases or lesions. According to one embodiment of the …